Read the most recent news on the Vybion's Huntington's Therapy from the Huntington's Disease News.
Roche Phase 3 Clinical Trial for Huntington’s Disease Gene-Silencing Drug to Enroll Volunteers – Early 2019
Dear friends in the fight against Huntington's disease, Pharma giant Roche expects to start enrolling subjects worldwide (including the U.S.) in early 2019 in its historic Phase 3 clinical trial…
Gene Silencing Therapies
Huntington's Disease News reports on a new treatment known as Gene Silencing Therapies. Read more by Victoria Tan here.
Joint Resolution: A Link Between Huntington’s Disease And Rheumatoid Arthritis
In the May publication of Science Magazine the University of California San Diego School of Medicine and the Icahn School of Medicine at Mount Sinai have discovered a link between Huntington’s…
New Signaling Pathway
Johns Hopkins researchers find possible pathway to protect cells against oxidative stress linked to Huntington’s disease. Read more from John Hopkins Medicine here.
Drug trial shows promising results to fight Huntington’s disease
New CNN report reveals promising trial to help fight Huntington's disease. Read more from CNN here.
CHALLENGING HUNTINGTON’S DISEASE
A lovely write up and tribute about the work HDCare is doing for the Huntington's community on Huff Post by Don C. Reed, titled: Benefit #4 (of 71) of the California…
UCI Team Finds Method to Reduce Accumulation of Damaging Huntington’s Disease Protein
A study appearing April 14 in the journal Neuron suggests there may be a new way to change the damaging course of Huntington disease. University of California, Irvine neurobiologists Leslie Thompson and Joseph…
Novel Compound Has Promise for Treatment of Huntington’s Disease
Mass. General-led study identifies molecular compound with two neuroprotective activities. Please join us in congratulating HD-CARE Scientific Advisory Board members, Dr. Malcolm Casale and Dr. Leslie Thompson and Dr. Ryan…